SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $278,806 | +5.9% | 2,300 | 0.0% | 0.05% | +9.3% |
| Q2 2023 | $263,396 | -16.9% | 2,300 | 0.0% | 0.04% | -23.2% |
| Q1 2023 | $317,009 | +6.4% | 2,300 | 0.0% | 0.06% | +3.7% |
| Q4 2022 | $298,034 | +17.3% | 2,300 | 0.0% | 0.05% | +3.8% |
| Q3 2022 | $254,000 | +22.7% | 2,300 | 0.0% | 0.05% | +62.5% |
| Q4 2021 | $207,000 | -2.8% | 2,300 | 0.0% | 0.03% | -13.5% |
| Q3 2021 | $213,000 | -45.7% | 2,300 | 0.0% | 0.04% | -51.9% |
| Q4 2020 | $392,000 | +21.4% | 2,300 | 0.0% | 0.08% | +1.3% |
| Q3 2020 | $323,000 | -28.1% | 2,300 | -17.9% | 0.08% | -46.1% |
| Q2 2020 | $449,000 | +63.9% | 2,800 | 0.0% | 0.14% | +50.0% |
| Q1 2020 | $274,000 | -33.7% | 2,800 | -12.5% | 0.09% | -15.3% |
| Q4 2019 | $413,000 | +65.9% | 3,200 | -3.0% | 0.11% | +54.2% |
| Q3 2019 | $249,000 | -50.3% | 3,300 | 0.0% | 0.07% | -50.3% |
| Q2 2019 | $501,000 | +27.5% | 3,300 | 0.0% | 0.14% | +22.9% |
| Q1 2019 | $393,000 | +9.2% | 3,300 | 0.0% | 0.12% | +3.5% |
| Q4 2018 | $360,000 | -32.5% | 3,300 | 0.0% | 0.11% | -25.5% |
| Q3 2018 | $533,000 | +22.2% | 3,300 | 0.0% | 0.15% | +11.7% |
| Q2 2018 | $436,000 | – | 3,300 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |